Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Singh brothers resign...

    Singh brothers resign from board of Religare Enterprises

    Written by Ruby Khatun Khatun Published On 2018-02-15T10:45:55+05:30  |  Updated On 15 Feb 2018 10:45 AM IST
    Singh brothers resign from board of Religare Enterprises

    New Delhi: Diversified financial services firm Religare Enterprises said Malvinder Mohan Singh and Shivinder Mohan Singh have resigned from the company's board with effect from February 14, 2018.


    "Malvinder Mohan Singh and Shivinder Mohan Singh have stepped down from the board of directors with effect from February 14, 2018," Religare Enterprises said in a regulatory filing informing about the changes in the composition of the board of directors of the company without giving any reasons.



    Also, Francis Daniel Lee, a non-executive non-independent director has resigned with effect from February 13, 2018, it said.








    Shivinder held the position as the non-executive vice chairman of the company and Malvinder as the non-executive non-independent director on the board, as per the company website.







    Religare Enterprises is the promoter of Fortis Healthcare and the two brothers had resigned from the board of directors of the latter last week following a Delhi High Court order upholding Rs 3,500 crore arbitral award in favour of Japan Daiichi Sankyo.


    Read also: Singh brothers resign from Fortis Healthcare board

    The resignation is intended to free the organization from any encumbrances that may be linked to the promoters, Fortis Healthcare had said.


    Fortis Healthcare has issued notices by the stock exchanges following a media report claiming that the company's promoters, the Singh brothers, took at least USD 78 million (about Rs 500 crore at current exchange rate) out of the publicly-traded hospital company they control without board approval about a year ago.


    Read also: Singh brothers took 78 million dollars out of Fortis: Report

    The Delhi High Court had on January 31 upheld an international arbitral award of Rs 3,500 crore passed in favour of Japanese pharma major Daiichi Sankyo, which has alleged that the former promoters of India's Ranbaxy Laboratories had concealed information about proceedings against them by American food and drug department.


    Read also:
    Rs 3,500 crore jolt to Singh brothers as Delhi High Court upholds the arbitral award

    Earlier, a tribunal in Singapore had passed the verdict in favour of Daiichi holding that the former Ranbaxy promoters and brothers, Malvinder and Shivinder, had concealed information that the Indian company was facing a probe by the US Food and Drug Administration and the Department of Justice while selling its shares.


    Religare also announced its third-quarter earnings and posted a net loss of Rs 41.67 crore. There was a net loss of Rs 43.27 crore in the same quarter of 2016-17.


    Total income of the company stood at Rs 7.96 crore for the quarter, slightly up from Rs 7.64 crore in the same period a year ago.

    arbitral awardDaiichi SankyoDelhi high courtFortis Healthcareinternational arbitral awardMalvinder Mohan SinghRanbaxy laboratoriesReligare EnterprisesresignresignationShivinder Mohan SinghSingh brothersUS Food and Drug Administration
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok